Total Funding
72
39
Total FundingSeries B raised
Growth Score 72 in past quarter
-7 pts
Heat Score 39 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30525
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
- Bruno Thiao-Layel: Co-Founder
- Louis Letinier: Co-founders
About the Company
At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone.
To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and
UI components that are used to prescribe, dispense, and manage medications across the entire patient journey.
Synapse is working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today’s medication regimens into tomorrow’s medication success.
